We’ve just received word that the NJ Supreme Court has ruled in the Sinclair Vioxx appeal:

“HELD: The Products Liability Act, which is the sole source of remedy for plaintiffs’ defective product claim, does not include the remedy of medical monitoring when no manifest injury is alleged.”

Until Herrmann gets a chance to read the opinion, we can’t comment any further, since Bexis represents Merck in Vioxx litigation.